Vyome gets USPTO notice of allowance for VT-1908 topical mycophenolate patent application

Bitget2026/10/05 12:10

Vyome received a USPTO Notice of Allowance for a U.S. patent application covering VT-1908, a topical ophthalmic mycophenolate program. Claims cover formulations and methods of use for inflammatory diseases, supporting IP protection around the candidate’s development plans. VT-1908 is being developed initially for anterior uveitis, targeting demand for steroid-sparing therapies in ocular inflammation. Vyome estimates the broader ocular inflammation market at more than $20 billion by 2035. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyome Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261005278681) on October 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Only 1.45 Billion Shiba Inu (SHIB) Burned in 24 Hours Hints at Reversal

UToday•2026/10/11 10:27

Viral Altcoin Defies Market Slumber With 53% Surge, BTC Calms at $83K: Weekend Watch

Cryptopotato•2026/10/11 10:21

Global Bank Stocks Sink as Bond Losses Top $326 Billion: Is Another SVB Coming?

BeInCrypto•2026/10/11 10:06

Exclusive Report - Sources Say INWIT Investors Are Raising Funds for a Possible Privatization Deal

路透社•2026/10/11 08:51